| Literature DB >> 34631145 |
Dawn Aitken1, Saliu Balogun2, Yi Chao Foong1,3, David Humphries4, Laura Laslett1, Nathan Pitchford5, Hussain Khan1, Johanne Martel-Pelletier6, Jean-Pierre Pelletier6, Francois Abram7, Xingzhong Jin8, Graeme Jones1, Tania Winzenberg1.
Abstract
BACKGROUND/AIM: The clinical relevance of MRI knee abnormalities in athletes is unclear. This study aimed to determine the prevalence of MRI knee abnormalities in Australian Rules Football (ARF) players and describe their associations with pain, function, past and incident injury and surgery history.Entities:
Keywords: Australian football; injury; knee; knee injuries; sports medicine
Year: 2021 PMID: 34631145 PMCID: PMC8483025 DOI: 10.1136/bmjsem-2021-001097
Source DB: PubMed Journal: BMJ Open Sport Exerc Med ISSN: 2055-7647
Figure 1Example of an incident bone marrow lesion in a player that reported having a knee injury during the season. A tibial bone marrow lesion (red arrow) has developed between the early season (A) and the end of season (B).
Characteristics of participants at baseline (n=75)
| Mean (range) or % (n/N) | |
| Age (years) | 21 (16–30) |
| Height (cm) | 183.6 (170.6–202.3) |
| Weight (kg) | 83.6 (67.0–109.4) |
| Years played AFL | 11 (1–21) |
| Leg strength (kg) | 187 (25–280) |
| Dominant kicking foot, right | 84% (53/63) |
| Previous knee injury (right or left) | 52% (39/75) |
| Right | 36% (27/75) |
| Left | 34% (25/74) |
| Previous knee surgery (right or left) | 9% (7/75) |
| Right | 9% (7/75) |
| Left | 3% (2/74) |
| VAS pain*, (right and left) | 17 (1–86) |
| Right | 14 (1–73) |
| Left | 20 (1–86) |
| KOOS total*, (right and left) | 17 (1–113) |
| Right | 15 (1–107) |
| Left | 18 (1–113) |
| MRI prevalence data | |
| Bone marrow lesions (right or left knee) | 67% (39/58) |
| Right knee | 59% (34/58) |
| Left knee | 47% (27/58) |
| Meniscal tear (right or left knee) | 14% (8/58) |
| Right knee | 12% (7/58) |
| Left knee | 3% (2/58) |
| Meniscal extrusion (right or left knee) | 2% (1/58) |
| Right knee | 2% (1/58) |
| Left knee | 0% (0/58) |
| Cartilage defects (right or left knee)† | 43% (25/58) |
| Right knee | 28% (16/58) |
| Left knee | 33% (19/58) |
| Suprapatellar effusion synovitis (right or left knee)† | 67% (39/58) |
| Right knee | 52% (30/58) |
| Left knee | 50% (29/58) |
*Summarised for those with VAS or KOOS scores>0.
†Defined as grade 2 or greater.
KOOS, Knee injury and osteoarthritis outcome score; n, total in sample; n, number with characteristic; VAS, visual analogue scale.
Cross-sectional associations between MRI abnormalities and knee pain and dysfunction
| Outcome variables | Bone marrow lesions | Cartilage defects* | Meniscal tears/extrusion | Effusion synovitis* | Synovial fluid volume | Synovial membrane thickness | ||||||
| Multivariable† | Multivariable‡ | Multivariable† | Multivariable‡ | Multivariable† | Multivariable‡ | Multivariable† | Multivariable‡ | Multivariable† | Multivariable‡ | Multivariable† | Multivariable‡ | |
| β (95% CI) | β (95% CI) | β (95% CI) | β (95% CI) | β (95% CI) | β (95% CI) | β (95% CI) | β (95% CI) | β (95% CI) | β (95% CI) | β (95% CI) | β (95% CI) | |
| VAS | 1.54 | −0.81 | 5.02 | 4.01 | 8.71 | 1.35 | 1.86 | −1.19 | 1.79 | 0.59 | 1.36 | 6.60 |
| KOOS total | 3.05 | −1.58 | 5.26 | 2.70 |
| 3.16 | 1.50 | −2.59 | 1.52 | −11.16 | −6.39 | |
|
| ||||||||||||
| Symptoms | 0.65 | 0.73 | 0.30 | 0.67 | 0.14 | −0.41 | 0.19 | −0.78 | −0.15 | |||
| Stiffness | 0.20 | −0.04 | 0.18 | 0.06 | 0.47 | −0.04 | −0.27 | 0.13 | 0.03 | −0.52 | −0.15 | |
| Pain | 0.0005 | −0.68 | 0.67 | 0.33 | 1.91 | 0.16 | −0.10 | −0.78 | 0.46 | 0.18 | −0.98 | 0.11 |
| Function | −0.71 | −1.72 | 1.24 | 0.79 | 2.70 | 0.55 | 0.19 | −0.45 | 0.54 | 0.17 | 0.37 | 1.49 |
| Sport | −0.47 | − | −0.22 | −0.82 | 1.09 | −0.82 | 0.36 | −0.25 | 0.30 | −2.43 | −1.85 | |
| Quality of life (QOL) | 0.30 | −0.33 | 0.15 | −0.24 | 1.30 | 0.04 | 0.47 | −0.09 | −1.22 | −0.07 | ||
Pain and dysfunction measures are the outcomes in these analyses. β coefficient represents the VAS/KOOS score in those with an MRI abnormality present, or per 1-unit increase in synovial fluid volume (mL) and synovial membrane thickness (mm).
Boldface denotes statistically significant result.
*Defined as grade 2 or higher.
†Adjusted for age, weight, and height.
‡Further adjusted for history of knee injury.
KOOS, knee injury and OA outcome score; VAS, visual analogue scale.
Cross-sectional associations between a history of knee injury or surgery and MRI abnormalities
| Outcome variables | History of knee injury | History of knee surgery | ||
| Univariate | Multivariable† | Univariate | Multivariable† | |
| RR (95% CI) | RR (95% CI) | RR (95% CI) | RR (95% CI) | |
| BMLs | 1.41 (0.99 to 2.02) | 1.30 (0.87 to 1.96) | 1.29 (0.64 to 2.59) | |
| Cartilage defects* | 1.27 (0.75 to 2.17) | 1.23 (0.70 to 2.17) | ||
| Meniscal tears/extrusion | ||||
| Effusion synovitis* | 1.41 (0.98 to 2.01) | 1.68 (0.97 to 2.91) | ||
|
|
|
|
| |
| Synovial fluid volume (mL) | 1.85 (−0.35 to 4.05) | |||
| Synovial membrane thickness (mm) | −0.01 (−0.09 to 0.08) | −0.01 (−0.10 to 0.08) | 0.04 (−0.04 to 0.12) | 0.03 (−0.06 to 0.12) |
MRI abnormalities are the outcomes in these analyses.
RR represents the risk of having an MRI abnormality present in those who had a previous knee injury or surgery.
Boldface denotes statistically significant result.
β coefficient represents the difference in synovial fluid volume (mL) and synovial membrane thickness (mm) in those who did and did not report a previous knee injury or surgery.
*Defined as grade 2 or higher.
†Adjusted for age, weight and height.
The association between incident knee injuries (n=10) and changes in pain, function and MRI abnormalities over the season
| Outcome variables | Incident knee injuries | |
| Univariable | Multivariable* | |
| β (95% CI) | β (95% CI) | |
| Change in VAS | ||
| Change in KOOS total | ||
|
| ||
| Change in symptoms | 1.58 (−0.27 to 3.43) | 1.68 (−0.18 to 3.54) |
| Change in stiffness | ||
| Change in pain | ||
| Change in function | ||
| Change in sport | ||
| Change in quality of life (QOL) | ||
| Change in synovial membrane thickness | 0.12 (−0.005 to 0.25) | 0.12 (−0.02 to 0.25) |
| Change in synovial fluid volume | 3.07 (−1.39 to 7.51) | 3.34 (−1.20 to 7.87) |
|
|
| |
|
|
| |
| Development of a new or enlarging BML† | ||
| Incident cartilage defects‡ | 5.12 (0.35 to 75.39) | |
| Incident meniscal damage (tear, partial or full extrusion) | ||
| Incident effusion synovitis‡ | 0.90 (0.11 to 7.49) | 0.28 (0.004 to 19.25) |
Changes in pain, function and MRI abnormalities are the outcome in these analyses.
RR represents the risk of worsening MRI abnormalities in those who had an incident knee injury.
Boldface denotes statistically significant result.
β coefficient represents the difference in change scores in those who did and did not report an incident knee injury.
*Adjusted for age, weight and height.
†Defined as an increase >25 mm2 in total size.
‡Defined as a new cartilage defect/effusion synovitis in those with a score <2 at baseline.
BML, bone marrow lesion; KOOS, knee injury and osteoarthritis outcome score; VAS, visual analogue scale.